Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Citius Oncology (CTOR)
NASDAQ:CTOR
Holding CTOR?
Track your performance easily
CTOR Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.85 - $49.00
Previous Close$0.98
Volume183.91K
Average Volume (3M)1.88M
Market Cap
$75.58M
Enterprise Value$77.30M
Total Cash (Recent Filing)$261.00
Total Debt (Recent Filing)$1.72M
Price to Earnings (P/E)4.0
Beta-1.00
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.24
Shares Outstanding2,355,249
10 Day Avg. Volume193,986
30 Day Avg. Volume1,876,198
Standard Deviation0.18
R-Squared0.00161
Alpha-0.05
Financial Highlights & Ratios
Price to Book (P/B)-0.76
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda676.03
Forecast
1Y Price Target
$3.00Price Target Upside206.72% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Citius Oncology News
CTOR FAQ
What was Citius Oncology’s price range in the past 12 months?
Citius Oncology lowest stock price was $0.85 and its highest was $49.00 in the past 12 months.
What is Citius Oncology’s market cap?
Currently, no data Available
When is Citius Oncology’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Citius Oncology’s earnings last quarter?
Currently, no data Available
Is Citius Oncology overvalued?
According to Wall Street analysts Citius Oncology’s price is currently Undervalued.
Does Citius Oncology pay dividends?
Citius Oncology does not currently pay dividends.
What is Citius Oncology’s EPS estimate?
Citius Oncology’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Citius Oncology have?
Citius Oncology has 71,304,050 shares outstanding.
What happened to Citius Oncology’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Citius Oncology?
Currently, no hedge funds are holding shares in CTOR
---
Citius Oncology Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$3.00 (206.72% Upside)
$3.00 (206.72% Upside)
Blogger Sentiment
Bullish
CTOR Sentiment 100%
Sector Average 65%
Sector Average 65%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-91.40%
12-Months-Change
Fundamentals
Return on Equity
3.35%
Trailing 12-Months
Asset Growth
-29.57%
Trailing 12-Months
Company Description
Citius Oncology
TenX Keane Acquisition is a newly incorporated blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.
---
CTOR Stock 12 Month Forecast
Average Price Target
$3.00
▲(206.72% Upside)
Technical Analysis
Best Analysts Covering CTOR
1 Year
1 Year Success Rate
1/1 ratings generated profit
1 Year Average Return
+12.70%
initiated a buy rating 25 days ago
Copying Michael Okunewitch's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +12.70% per trade.
---